The X-linked form of chronic granulomatous disease (X-CGD) results from mutations in the gene encoding gp9lPhox, a 91-kD membrane glycoprotein that is the larger subunit of the respiratory burst oxidase cytochrome b. In this study, a new retroviral vector for expression of human gp91PhoN, MSCV-h91Neo. based on murine stem cell virus vectors, was evaluated using a human X-CGD myeloid cell line (X-CGD PLB-985 cells) and murine bone marrow cells. Expression of recombinant gp9IPho" in transduced X-CGD PLB-985 cells was substantially improved compared with levels achieved previously using a different retroviral construct, and respiratory burst oxidase activity was fully reconstituted in the majority of clones analyzed. Expression of gp9lPho" transcripts was also observed in primary and secondary murine colony-HRONIC granulomatous disease (CCD) is an inherited disease in which any one of four subunits of the phagocyte respiratory burst oxidase (NADPH-oxidase) is defective, resulting in life-threatening bacterial and fungal infections due to a deficiency in microbicidal oxidants.' Mutations in the X-linked gene for gp9IPhox, a 91-kD membrane glycoprotein that is the larger subunit of the oxidase cytochrome b, account for two thirds of cases (X-CCD). A rare autosomal recessive form of CGD results from defects in the gene encoding p22"*", a 22-kD peptide that is the smaller subunit of cytochrome b. The remaining two autosomal recessive subgroups involve mutations in one of two soluble proteins of the oxidase complex, ~47"""" and ~6 7~" " " .
HRONIC granulomatous disease (CCD) is an inherited
disease in which any one of four subunits of the phagocyte respiratory burst oxidase (NADPH-oxidase) is defective, resulting in life-threatening bacterial and fungal infections due to a deficiency in microbicidal oxidants.' Mutations in the X-linked gene for gp9IPhox, a 91-kD membrane glycoprotein that is the larger subunit of the oxidase cytochrome b, account for two thirds of cases (X-CCD). A rare autosomal recessive form of CGD results from defects in the gene encoding p22"*", a 22-kD peptide that is the smaller subunit of cytochrome b. The remaining two autosomal recessive subgroups involve mutations in one of two soluble proteins of the oxidase complex, ~47"""" and ~6 7~" " " .
Current management of CGD includes the prophylactic use of antibiotics' and interferon-y,3 but the disorder can still be associated with considerable morbidity, especially in the X-linked form of the d i~e a s e .~ Murine models of X-linked' and autosomal recessive' CCD have recently been developed that should prove useful in investigating new therapeutic approaches to this disorder. Because the genetic defect in X-CGD affects cells of the hematopoietic system, retrovirus-mediated gp91Ph"' gene transfer into hematopoietic stem cells is one strategy that may provide a lifelong cure. Complete correction of respiratory burst activity in even as few as 10% of circulating phagocytes might ameliorate the increased susceptibility to infection in CCD, as inferred from studies of female carriers of X-linked CCD.' The relative level of respiratory burst oxidase activity within individual phagocytes, however, may also be an important determinant in the outcome of gene replacement therapy. "Variant" patients with X-linked CGD who have some residual respiratory burst activity can still develop severe infectious complications,'.' and in vitro killing of Staphylococcus aureus by neutrophils from such patients has been shown to be markedly abnormal.' These observations suggest that a partial correction of respiratory burst oxidase activity may not be sufficient to restore full microbicidal function to the phagocyte.
C
Reconstitution of phagocyte respiratory burst activity in the gp9lP""', ~2 2 / '~" , and p47"*" deficient forms of CGD has been achieved in granulocytes and monocytes cultured in vitro after transduction of peripheral blood stedprogenitor cells by simplified retroviral vectors.'".'' The relative level of superoxide generation by phagocytes derived from transduced cells could not be measured directly in these studies. Our laboratory has also developed a simplified retroviral vector, ZipPGKgp9 1, for expression of the human gp9lPh"" cDNA and characterized its activity in clonal populations isolated after transduction of a human X-CGD phagocyte cell line." This cultured cell model of X-CGD was derived from PLB-985 myeloid leukemia cells by disruption of the gp91Ph"x gene using gene targeting." Expression of recombinant gp91''h" protein in ZipPGKgp91-transduced X-CCD PLB-985 cells was, on average, 5% of wild-type levels, and respiratory burst oxidase activity was only partially reconstituted."
In the present study, we report the functional characterization of a new retroviral vector, MSCV-h91Neo, which contains the cDNA for human gp91Ph"' along with a downstream expression cassette for neomycin phosphotransferase. The murine stem cell virus (MSCV) vectors were designed for efficient transduction and expression of genes in primitive hematopoietic cells and their progeny and contain modified myeloproliferative sarcoma virus LTRs and an optional selectable marker." We found that MSCV-h91Neo substantially improved recombinant gp91'""' expression in transduced X-CGD PLB-985 cells, which led to high levels of respiratory burst oxidase activity in this model system. Furthermore, the MSCV-h91Neo vector also conferred functional expression of gp9Ip"'" in progeny of transduced X-CGD murine bone marrow (BM) cells cultured in vitro, which is the first report demonstrating genetic correction of the enzymatic defect in murine CGD phagocytes. These data suggest that the MSCV-h91Neo vector may be useful for therapeutic retroviral-mediated gene transfer in X-CGD.
MATERIALS AND METHODS
Cell lines. NIH 3T3 fibroblasts (provided by D.A. Williams. Indiana University School of Medicine, Indianapolis) were cultured in Dulbecco's modified Eagle's medium (GIBCO, Grand Island, NY) with 10% newborn bovine serum (Sigma, St Louis, MO), 100 U/mL penicillin (Sigma), and 1 0 0 pg/mL streptomycin (Sigma) (P/ S). Retrovirus packaging lines GP+ E86 (E86) and GP+ envAm12 (Am12) were obtained from A. Bank (Columbia University, New York, NY) and cultured in DMEF-I2 medium with 10% fetal calf serum (FCS) (Sigma), 1% P/S, I % glutamine (GIBCO), and 0.1 molL HEPES (GIBCO). Wild-type and X-CCD PLB-985 cells were cultured in RPM1 medium with 10% FCS, I% P/S, and l % glutamine, granulocytic differentiation induced with dimethyl-formamide as described."
Retroviral vector and producer cells. The human gp9 I~'""' cDNA was cloned into an Xho I restriction site downstream of the LTR in the MSCVneoEB shuttle plasmid. A phosphoglyero kinase (PGK) promoter-controlled expression cassette for neomycin phosphotransferase (neo) is located 3' of hgp9Ip'"" cDNA (Fig l) . This construct, MSCV-h9INeo, was transfected into E86 packaging cells using the DOTAP transfection reagent (Boehringer-Manheim, Indianapolis, IN). Transfected packaging cells were selected in 0.8 mg/mL G418 (dry powder) (GIBCO). The ecotropic producer clone that had highest G418-resistance titer on 3T3 cells (2 X l@ cfu/mL) was ex-1835 panded. Virus-containing supernatant was collected by adding 4 mL of a-minimal essential medium (@"EM) containing 109 FCS to IO-cm confluent plates overnight. Obtained medium was filtered (0.45 pm) and stored at -80°C until use.
To make an amphotropic MSCV-h9lNeo packaging line. Am12 packaging cells were infected with the high titer ecotropic MSCVh91Neo vector by supernatant "ping-pong." Briefly, Am12 cells were incubated with MSCV-h9INeo retroviral supernatant in the presence of polybrene (X pg/mL) (Aldrich Chemical CO, Milwaukee, WI) for 2 hours on three successive days. A clone with a titer of 1 X 10' cfu/mL, identified as described above, was used for transduction of PLB-985 cells.
To confirm the (3418-resistance titer and packaging of intact retrovirus by the ecotropic and amphotropic lines, RNA titering was done by incubating SO% confluent 3T3 cells with retroviral supernatant at a 1:10 dilution for 2 hours in the presence of 8 pg/mL polybrene, extracting RNA from these cells 2 days later and performing Northern blot assay using the neo cDNA as a probe. Both ecotropic and amphotropic producer cells contained intact retrovirus as shown by the appearence of neo-containing transcripts of the expected sizes (data not shown).
Trunsrluction o f X-CCD PLB-985 cells. X-CCD PLB-985 cells were transduced using a 2-day coculture infection protocol with amphotropic producer cells pretreated with mitomycin c as described." The transduced X-CGD PLB-985 cells were then plated onto 96-well plates at limiting dilution in the presence of 1.5 mgl mL G418. At day 12, (3418-resistant clones were randomly picked and expanded. Nine clones were assayed for the expression of provirus RNA, gp91"""' protein, and respiratory burst activity after granulocytic differentiation with dimethylformamide as described." In most cases, data from all three assays were obtained on each clone, except as noted.
Trmsduction qf wild-type murine CFU-S. Wild-type C57B 1/65 mice were injected intraperitoneally with IS0 mg/kg S-fluororacil (S-FU: Solo Pak Laboratory Inc, Elk Grove Village. IL). and BM cells were obtained from mice 2 days postinjection. The cells were plated at a density of 2 X IO7 cellsllO-cm dish and prestimulated for 2 days in a-MEM containing 30% heat-inactivated fetal bovine serum, glutamine, P/S, 100 UlmL recombinant human interleukin-6 (rhlL-h) (PeproTech, Rock Hill, NJ). and 1 0 0 n@mL recombinant murine stem cell factor (rmSCF) (Genzyme, Cambridge. MA). On day 3.4 X IO6 cells were plated on a IO-cm dish containing mitomycin c-treated viral producer cells plated the previous day at 3 X 10" cells per dish, and cocultured for 2 additional days under the same growth factor conditions in the presence of 4 pg/mL polybrene. Lethally irradiated ( 1 I Cy) (cesium-137 using a gamma cell 40; Nordion International Inc. Kanata, Ontario, Canada) wild-type CS7B116J recipient mice were given I X IO' to 2 X I O ' cells per mouse intravenously to obtain individual colony-forming unit spleen (CFU-S) foci. For secondary CFU-S-12 foci, approximately one half of the cells of single CFU-S-14 colonies were transplanted into each lethally irradiated secondary recipient. Individual CFU-S colonies were dissected on days 12 or 14 posttransplantation and examined for provirus integration and expression by Southern and Northern blot analyses. respectively. concentration of 4 pg/cm' as previously described." X-CGD donor mouse BM was harvested from 6-to 8-week-old mice, and I X 10" cells/mL nonadherent BM cells were exposed to ecotropic retroviral supernatant for I to 2 days on fibronectin-coated dishes in a-MEM containing 30% FCS (Hyclone Laboratories. Logan. UT), I O 0 U/ mL rhIL-6. and 100 nglmL rmSCF. BM cells were then collected For personal use only. on October 31, 2017. by guest www.bloodjournal.org From by cell dissociation buffer and plated for high-proliferative potential (HPP) progenitors. As controls. mock infections of X-CCD and wild-type BM were done under the same conditions as above except using a-MEM medium instead of rctroviral supernatant.
HPP progenitor colonies were grown in 35-mm tissue culture dishes using double-layer agar as described previously."' Briefly. growth factors ( 100 ng rmSCF. 1.600 U human macrophage colonystimulating factor (hMCSF), 200 U rmlL-3, and 1 , 0 0 0 U rmlL-la) (hMCSF and rmlL-la from Genzyme: rmIL-3 from PeproTech) were incorporated into I-mL underlays with 0.5% agar and a-medium with 20% FCS. Retrovirus supernatant-infected and mockinfected BM cells were plated at 2.5 X 10' to S X IO' cells per dish in a 0.5-mL 0.3% agar overlay with medium and FCS. Plates were incubated in 5% 0 2 . 1 0 % CO, at 37°C for 14 days. To analyze transduction efficiency and reconstitution of respiratory burst activity, an in situ nitroblue tetrazolium (NBT) test was performed by overlaying 0.4 mL of a saturated solution of NBT with S00 nglmL phorbol myristate acetate (PMA) onto each day-14 HPP dish and incubating for 2 hours at 37°C. Those colonies in which a portion of the cells accumulated dark formazan deposits from reduction of NBT by superoxide were scored positive. Wild-type and transduced or mock-infected X-CCD BM cells were also expanded in a liquid culture system at I X IO' cellslmL in a-MEM with 20% FCS and 300 units recombinant human granulocyte colony-stimulating factor (rhG-CSF) (Amgen Biologicals) for an additional 1 I days, refeeding with an additional 300 U G-CSF every 2 days. The NBT slide test" was performed on the expanded cells, which contained a mixture of differentiating granulocytes and macrophagelmonocytes. The oxidase was activated by phorbol myristate acetate in the presence of NBT. which is converted into insoluble dark purple formazan deposits by superoxide. After 40 minutes at 37°C. slides were fixed and counterstained with safranin.
DNA. RNA, cInc1 immlrnohlor crricr1wi.s. DNA was extracted using lsoquick (Microprobe Corporation, Bothell. WA) according to the manufacturer's instructions. Genomic DNA was cut with K p~z I to assess provirus copy number or Xho I to examine the number of junctional fragments, using the neo cDNA as a probe (see Fig I) . Total RNA was extracted by guanidine thiocyanate and separated on a formaldehyde agarose gel as described.'' Southern and Northern transfers to Magnacharge nylon membrane (Micron Separations, Westboro. MA) were performed using standard protocols supplied by the manufacturers. Blots wcre probed with cDNA fragments derived from either the gp91"""' or neo cDNAs. as previously described." Cellular proteins were extracted using a buffered I % Triton X-IO0 solution. and electrophoresis, immunohlotting, and scanning densitometry were performed as previously described." (Fig 2) . which was the size predicted for the unspliced viral S'-LTR transcript ( Fig   I) . Very little. if any, of the spliced transcript was detectable.
A clone-toclone variation in the level of vector derived RNA was observed. which was unrelated to copy number but did correlate with gp9lP""' protein levels (see below). To examine expression of gp91/""" in the transduced X-CGD PLB-985 clones, protein was extracted from granulocyte-induced cells and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting with a monoclonal antibody for gp91'""' (Fig 3) . Before transduction, no gp9Ip""' was detected in X-CGD PLB-985 cells. Immunoreactive gp9Ir""" protein was detected in all transduced clones, with the level in different clones ranging from 6% to 48% (mean, 25%) of that present in wild-type PLB-985 cells (Table I) , as estimated by scanning densitometry of the gp91/"'"' signal.
Respiratory burst oxidase activity. as measured by the quantitative cytochrome c assay. was partially or completely reconstituted in X-CGD PLB-985 cells after transduction with MSCV-h9INeo ( Table I ). oxide production in transduced clones ranged from 57% to 119% (mean. 88%) of wild-type levels.
Clones 3 and 5 , which contained the lowest levels of gp91'""" protein, exhibited rates of superoxide formation that were approximately 50% of wild-type. with the remaining clones having oxidase activity in the wild-type range.
E.rpression nrtcl.fitrlctiorr of MSCV-h9INeo in priman murine kentaropietic cells. Expression of vector-derived mRNAs in primary hematopoietic cells was assessed by Northern blot analyses of CFU-S-I2 and CFU-S-14 derived from MSCV-h91 Neo-transduced murine BM cells. Genomic Southern blot showed 7 of 7 (100%) CFU-S-12 colonies that contained one to two copies of the integrated provirus, except for one clone, which had four copies (data not shown). In two additional experiments, 24 of 28 (86%) CFU-S-12/14 and 2 of 12 secondary CFU-S-12 colonies expressed provirus-derived transcripts as shown by Northern blot (Fig 4) . The unspliced LTR-driven message was the most abundant vector-derived transcript in the majority of CFU-S. The level of this transcript varied in different colonies and was relatively lower in the two RNA-positive secondary CFU-S comc ---" pared with the range seen in primary CFU-S and in transduced X-CGD PLB-985 cells.
To assess the functional expression of gp91"""' in primary hematopoietic cells after MSCV-h91 Neo transduction, X-CGD mouse BM was transduced with virus supernatant and plated for HPP colonies. Colonies were not selected for G41 8 resistance, because cells derived from the X-CGD mice contain a functional PGK-neo transgene.5 Respiratory burst activity, as monitored by the NBT test, was detected in 6% to 21% of day-l4 HPP derived from transduced X-CGD BM, whereas no positive colonies were noted in HPP derived from mock-infected X-CGD BM (Table 2) . Functional expression of human gp91"""' in progeny of murine X-CGD BM cells transduced with MSCV-h91Neo was confirmed by the reconstitution of respiratory burst activity, as assayed by the NBT slide test, in a subpopulation of neutrophils differentiated in a liquid culture system (Fig S ) . In this experiment, 8% of X-CGD neutrophils derived from transduced X-CGD BM cells were NBT-positive, with a degree of formazan staining that was comparable in intensity with that observed for neutrophils differentiated from wild-type mu- PLB-985 cell lines were induced to differentiate with 0.5% DMF for 6 days. Superoxide formation was measured by a continuous cytochrome c reduction assay. Data for superoxide formation are the mean t SD. The relative superoxide-generating was calculated from the mean nmol/ 0;/30 minll0' cells. The relative level of gp91PhoX was estimated using scanning densitometry of a representative immunoblot probed with a gp9lPho" antibody.
For Actinin the two secondary CFU-S-12 that were positive rine BM, 87% of which were NBT-positive. Although the NBT test is not a quantitative measurement of respiratory burst activity, the density of formazan deposits in activated phagocytes does reflect the relative level of superoxide generation as measured by the cytochrome c assay." For example, neutrophils from "variant" X-CGD patients with residual respiratory burst activity exhibit weakly positive NBT-staining.X.'X Again, no NBT-positive neutrophils were observed in mock-infected murine X-CGD BM cells. The apparent lower rates of gene transfer in the above experiments, as assessed by the frequency of NBT-positive cells, compared with the CFU-S 12 studies described above, are likely to be related to the differences in transduction protocols (see Materials and Methods).
DISCUSSION
These studies demonstrate that retroviral-mediated gene transfer of human g~91~"'".~, the protein that is defective in the X-linked form of chronic granulomatous disease, can confer high-level reconstitution of respiratory burst activity in a cultured cell model of human X-CGD phagocytes and restore superoxide production to murine X-CGD phagocytes. as an in vitro model of X-CGD phagocytes. In transduced X-CGD PLB-985 cells, the level of recombinant gp91/""" protein was, on average, 25% of wild-type levels, which was a fivefold improvement over what had been previously observed using the ZipPGK-gp91 retrovirus." The reason for the higher levels of gp91"""' protein expression is uncertain. In Zip/ PGK-gp91 -transduced cells, vector gp9lP"'" transcripts were derived almost entirely from the Maloney murine leukemia virus LTR and wcrc comparablc in abundance to wild-type PLB-985 granulocyte gp91"""' mRNA. However, recombinant gp9IP"",' protein levels were low, suggesting inefficient translation, possibly due to secondary structure in a PGK promoter sequence immediately upstream of the gp91""'" cDNA. In the MSCV-h91Neo vector, a modified myeloproliferative sarcoma virus LTR drives gp91p""" expression. The level of vector-derived gp9IP""' transcripts varied in different transduced clones and, in some cases, exceeded expression of the endogenous gp91p"".r mRNA in wild-type PLB-985 granulocytes. The reason for the clonal variation in expression did not appear to be related to the number of proviral integrations, suggesting that integration into some chromosomal sites may be less favorable for transcription. Amounts of recombinant gp91"""' protein correlated with the abundance of the proviral transcript but were still below wildtype protein levels, again suggesting some inefficiency in translation.
Importantly, the improved levels of recombinant gp9lP""" protein expression resulted in substantial respiratory burst oxidase activity in MSCV-h91Neo-transduced X-CGD PLB-985 cells, which was ir? the normal range in the majority of clones analyzed. Even clones with as little as =6% of wildtype protein levels exhibited almost 50% of wild-type levels of superoxide formation. These data are consistent with our previous results indicating that relatively small amounts of gp91p'"" expression can reconstitute considerable superoxide-generating activity.",'" The ability to restore high levels of enzyme activity to deficient phagocytes may be critical to the success of future clinical gene transfer applications, as X-CGD patients with low residual levels of oxidase activity can still experience a severe clinical course.'.'' Because vector function in permanent cell lines does not always predict expression in primary hematopoietic cells, we also evaluated MSCV-h91 Neo function in wild-type and X-CGD murine BM cells. Expression of vector-derived transcripts was observed in both primary and secondary CFU-S-l2 colonies, which exhibited a clone-to-clone variation in abundance similar to that observed for MSCV-h91Neo-transduced PLB-985 cells. The relative level of LTR-driven mRNA was lower in the secondary CFU-S-12 compared with that seen in primary CFU-S-12 and in X-CGD PLB-985 cells. Whether this reflects a consistent decrease in LTR function in more primitive hematopoietic cells cannot be determined in these studies. Promoter suppression in retrovirus vectors that have two promoters has been reported, particularly after transduction of primary cells." Both LTRderived gp91'"'" transcripts and PGK promoter-driven neo transcripts were detected in the majority of MSCV-h9 1 Neotransduced CFU-S colonies. However, further studies evaluating long-term expression in vivo will be required to determine whether suppression of the LTR-derived transcript in bone marrow cells occurs over time.
MSCV-h9 1 Neo-mediated expression of human gp9 Ir""' also reconstitutes the respiratory burst enzyme defect in granulocyte-monocyte cells of the X-CGD mouse, which is the first reported use of gene transfer to correct the functional defect in murine CGD phagocytes. Superoxide formation in progeny of transduced X-CGD BM cells, as assayed by the NBT test, was observed in both neutrophils differentiated from progenitors in a liquid culture system and in HPP colonies. The ability of the human gp9lP"" protein to complement the murine oxidase complex is consistent with the conserved nature of the enzyme subunits among different to reconstitute superoxide formation in human X-CGD PLB-985 cells.26 The amino acid sequence of human gp9Ir'"".' differs in only 39 of 570 residues from its murine homospecies.6.?3-?5 The murine g~91""".~ has previously been shown For personal use only. on October 31, 2017. by guest www.bloodjournal.org From logue, with the majority of differences being conservative substitutions that occur outside of putative heme-binding and flavoprotein domains.26
In conclusion, the MSCV-h91Neo retrovirus is a promising vector for gene therapy of X-linked CGD. High levels of respiratory burst oxidase activity were reconstituted in a human X-CGD phagocyte cell line, a factor that may be important in full restoration of phagocyte microbicidal activity and correction of the defect in host defense in vivo. Transduction of BM cells obtained from X-CGD mice also resulted in expression of functional gp9lPhoX in granulocytemonocyte progeny cultured in vitro. An important remaining question from the standpoint of gene replacement therapy is the longevity of provirus expression in vivo after transduction of reconstituting hematopoietic stem cells with MSCVh91Ne0, which is presently under investigation in the X-CGD mouse.
